Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.76
-0.1200-1.35%
Post-market: 8.800.0400+0.46%17:36 EDT
Volume:2.42M
Turnover:21.15M
Market Cap:1.83B
PE:-33.76
High:8.87
Open:8.87
Low:8.69
Close:8.88
Loading ...
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 07, 2022

Major Issues Report

8-K - Current report
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 24, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Major Issues Report

8-K - Current report
Sep 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 20, 2021

Major Issues Report

8-K - Current report
Sep 01, 2021

Major Issues Report

BIOCRYST PHARMACEUTICALS INC
Sep 01, 2021

Major Issues Report

8-K - Current report